Search Results - "Yip, Po Y."

A comparison of the outcomes of pulmonary versus extrapulmonary extensive-stage small cell carcinoma by Chen, Emily, Yip, Po Y, Tognela, Annette, Gandy, Geovanny, Earl, Clare, Tran, Patrick, Kok, Peey-Sei

“…Extrapulmonary small cell carcinomas (EPSCCs) are rare cancers, comprising 0.1-0.4% of all cancers. The scarcity of EPSCC studies has led current treatment…”
Get full text

Utility of multigene panel next‐generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer by Nindra, Udit, Pal, Abhijit, Bray, Victoria, Yip, Po Y., Tognela, Annette, Roberts, Tara L., Becker, Therese M., Williamson, Jonathon, Farzin, Mahtab, Li, Jing J., Lea, Vivienne, Hagelamin, Abeer, Ng, Weng, Wang, Bin, Lee, C. Soon, Chua, Wei

“…Background The standard of care in newly diagnosed metastatic non‐small cell lung cancer (NSCLC) is to test for aberrations in three genes for driver mutations…”
Get full text

Screening for ROS1 gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target by Selinger, Christina I, Li, Bob T, Pavlakis, Nick, Links, Matthew, Gill, Anthony J, Lee, Adrian, Clarke, Stephen, Tran, Thang N, Lum, Trina, Yip, Po Y, Horvath, Lisa, Yu, Bing, Kohonen‐Corish, Maija R J, O'Toole, Sandra A, Cooper, Wendy A

“…Aims To assess the prevalence of ROS1 rearrangements in a retrospective and prospective diagnostic Australian cohort and evaluate the effectiveness of…”
Get full text

Patients' perception of the benefits of palliative systemic therapy for advanced cancer by Subramaniam, Shalini, Adams, Diana H, Tognela, Annette, Roncolato, Felicia, Yip, Po Y, Lim, Stephanie H-S, Roohullah, Aflah, Stockler, Martin R, Kiely, Belinda

“…Patients with advanced cancer who misunderstand their prognosis and chance of cure tend to overestimate the likely benefits of palliative systemic therapy. To…”
Get full text

Clinical outcomes in patients with advanced epidermal growth factor receptor‐mutated non‐small‐cell lung cancer in South Western Sydney Local Health District by Ding, Pei N., Roberts, Tara L., Chua, Wei, Becker, Therese M., Descallar, Joseph, Yip, Po Y., Bray, Victoria

“…Background Epidermal growth factor receptor (EGFR)‐mutated non‐small‐cell lung cancer (NSCLC) is a subgroup of oncogene addicted lung cancer that predicts…”
Get full text

Screening for ROS 1 gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target by Selinger, Christina I, Li, Bob T, Pavlakis, Nick, Links, Matthew, Gill, Anthony J, Lee, Adrian, Clarke, Stephen, Tran, Thang N, Lum, Trina, Yip, Po Y, Horvath, Lisa, Yu, Bing, Kohonen‐Corish, Maija R J, O'Toole, Sandra A, Cooper, Wendy A

Get full text